InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+80.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Usman Nassim, Chairman & CEO. Insider active across 2 companies, notably Catalyst Biosciences, INC.. Aggregated, 8 filings have been recorded. Breakdown: 3 buys · 0 sell. Total volume traded: €5k. History available since 9 August 2021. The latest transaction was filed on 28 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Usman Nassim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
3,452 shares@ US$6.935.5% of flowCommon StockSEC:0001140361-24-032024:0
20,000 shares@ US$6.9331.7% of flowCommon StockSEC:0001140361-24-024125:0
20,000 shares@ US$6.9331.6% of flowCommon StockSEC:0001140361-24-017566:0
20,000 shares@ US$6.9331.2% of flowCommon StockSEC:0001140361-24-014164:0
24.541 sharesSeries Y Preferred StockSEC:0001140361-23-042367:0
3,250 shares@ US$0.4718.4% of flowCommon StockSEC:0001209191-22-045256:0
Canonical exit: 7 Nov 2022 (T+90)
3,250 shares@ US$0.4623.9% of flowCommon StockSEC:0001209191-22-010407:0
Canonical exit: 10 May 2022 (T+90)
867 shares@ US$3.6248.8% of flowCommon StockSEC:0001209191-21-050759:0
Canonical exit: 7 Nov 2021 (T+90)
8 of 8 declarations
About Usman Nassim
USMAN NASSIM is President & CEO. He has 8 filings in total, and within the recent filings held, buys total 5479 EUR and sells total 0 EUR, from 2021-08-11 to 2024-07-01. His listed companies are GYRE THERAPEUTICS, INC., where he is a Director, and Catalyst Biosciences, INC., where he is President & CEO. The most common transaction nature is Option exercise.
